Reglan Receives Black Box Warning for Tardive Dyskinesia
Last Updated on January 11, 2022
Attorneys working with ClassAction.org are no longer investigating this matter. The information here is for reference only. A list of open investigations and lawsuits can be viewed here.
At A Glance
- This Alert Affects
- Patients who have taken Reglan or metoclopramide and developed tardive dyskinesia.
- Some Reglan users have developed the neurological disorder tardive dyskinesia which causes rapid eye blinking, lip smacking, lip puckering and involuntary movement of the fingers, hands, arms and legs. Patients with tardive dyskinesia may also experience difficulty walking, talking, breathing and swallowing.
- Baxter Pharmaceutical and Schwarz Pharma Inc.
- Additional Details
- Reglan and other metoclopramide-containing drugs are prescribed to treat gastrointestinal disorders including acid reflux disease, gastroesophageal reflux disease (GERD) and diabetic gastroparesis. Metoclopramide may also be prescribed to treat nausea and vomiting related to chemotherapy or post-operative side effects.
- Reglan and metoclopramide-containing drugs have not been recalled, but received a black box warning in February 2009.
Reglan (generic: metoclopramide) is a prescription drug used to treat gastrointestinal disorders including acid reflux disease, gastroesophageal reflux disease and diabetic gastroparesis. Prescribed to more than 2 million Americans, Reglan received a black box warning from the FDA. The black box warning states that those taking Reglan (metoclopramide) for long-term treatment or in high doses are at risk for a neurological disorder known as tardive dyskinesia.
If you or a loved one has developed tardive dyskinesia after taking Reglan or other metoclopramide-containing drugs, you may be entitled to financial compensation.
Tardive Dyskinesia: Neurological Side Effects
Tardive dyskinesia is a disorder that causes involuntary movements of the face and extremities. Symptoms of this Reglan side effect include facial grimacing, lip smacking, lip puckering, tongue thrusting, rapid eye blinking and abnormal movements of the face, mouth, hands, arms, fingers and legs. In some cases, patients with tardive dyskinesia may also experience trouble swallowing, talking, walking and breathing. Currently, there is no treatment for tardive dyskinesia and the symptoms are rarely reversible. Reglan patients at greatest risk for tardive dyskinesia include the elderly, particularly older women, and those taking metoclopramide-containing drugs for long periods of time.
Class Action Lawsuit
Lawsuits have alleged that the manufacturers of metoclopramide-containing drugs like Reglan did not adequately explain the drug’s side effects and uses. Many physicians were unaware that these drugs are only intended for short-term treatment (no more than 3 months) when conventional methods fail. However, reports have suggested that one-third of patients took Reglan for a year or longer.
Metoclopramide-containing drugs can be injected to prevent chemotherapy-related and post-operative nausea and vomiting. The drug can also be orally administrated through a syrup or tablet form to treat gastrointestinal disorders. If you or a loved one has taken this drug and developed tardive dyskinesia, you may be able to recover financial compensation through a lawsuit.
Before commenting, please review our comment policy.